SEMA: Is it a case of thinking about current WW members getting into weight loss drugs or that the telemedicine company ultimately will help you attract more WW customers? Seemie: We looked at over 30 different startups and landed on sequence because they have built a tech stack better than anyone else. SEMA: There is a bit of a controversy around O'Zembix. So I'm curious if you can share with us and our listeners what is your criteria around prescribing it?Seemie: When people are looking for clinical intervention, and the benefit of the combination with Weight Watchers is when it is not medically appropriate.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Madison Mills
Hear the show live at 3PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno @madisonmills22 and @BW
See omnystudio.com/listener for privacy information.